ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,410, issued on May 27, was assigned to ELPISCIENCE (SUZHOU) BIOPHARMA LTD (China).
"Anti-CD39 antibodies" was invented by Yangsheng Qiu (Shanghai), Meiling Sun (Shanghai), Roumei Xing (Shanghai), Dan Xu (Shanghai), Yufei Shi (Shanghai), Jinfeng Zhao (Shanghai), Qinglin Du (Shanghai), Zhihao Wu (Shanghai), Rui Gao (Shanghai), Robert H. Arch (Shanghai) and Hongtao Lu (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-CD39 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof."
The patent was filed on Aug. 26, 2020, under...